NASDAQ:CELL - Nasdaq - US0843101017 - Common Stock - Currency: USD
PHENOMEX INC
NASDAQ:CELL (9/29/2023, 8:22:41 PM)
After market: 0.999 +0 (+0.09%)0.9981
+0 (+0.31%)
The current stock price of CELL is 0.9981 USD. In the past month the price increased by 5.06%.
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding...
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, is pleased to announce that GSK will present data on the SpotLightâ„¢ Human...
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, today announced it will showcase their latest optofluidic and proteomic...
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch of Meteorâ„¢ chips on the IsoSparkâ„¢ platform,...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 27.34 | 228.64B | ||
DHR | DANAHER CORP | 29.74 | 160.88B | ||
A | AGILENT TECHNOLOGIES INC | 28.64 | 43.21B | ||
IQV | IQVIA HOLDINGS INC | 18.54 | 36.55B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 35.77 | 28.79B | ||
WST | WEST PHARMACEUTICAL SERVICES | 50.53 | 24.74B | ||
WAT | WATERS CORP | 36.48 | 24.67B | ||
ILMN | ILLUMINA INC | 76.73 | 21.05B | ||
ICLR | ICON PLC | 14.19 | 16.44B | ||
RVTY | REVVITY INC | 26.67 | 15.35B | ||
AVTR | AVANTOR INC | 22.73 | 15.16B | ||
TECH | BIO-TECHNE CORP | 41.09 | 11.69B |
PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.
PHENOMEX INC
5858 Horton Street, Suite 320
Emeryville CALIFORNIA US
Employees: 285
Company Website: https://www.phenomenex.com/
Phone: 15108582855.0
The current stock price of CELL is 0.9981 USD.
The exchange symbol of PHENOMEX INC is CELL and it is listed on the Nasdaq exchange.
CELL stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CELL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CELL.
CELL does not pay a dividend.
CELL will report earnings on 2023-11-06, after the market close.
CELL does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.38).
ChartMill assigns a technical rating of 7 / 10 to CELL.
ChartMill assigns a fundamental rating of 3 / 10 to CELL. While CELL seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months CELL reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by -9.52% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -69.85% | ||
ROE | -111.9% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 51% to CELL. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 17.97% and a revenue growth -10.41% for CELL